| Code | 5739D | ||||||||||
| MA number | 42/0190/87-CS | ||||||||||
| Product Form: | sus por 1x125 ml (fľ.skl.jantár.+kovový uzáver) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | amber glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 21.10.1987 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Zovirax sus por_03.2021.pdf
|
| SPC: |
SPC_Zovirax sus por_03.2021.pdf
|
| Safety feature | Yes |
| Data update: | 16.10.2020 |
